Granite Point Capital Management, L.P. - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 2 filers reported holding SOLENO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$489,000
-17.1%
2,646,8500.0%0.12%
+1.6%
Q1 2022$590,000
+70.0%
2,646,850
+212.6%
0.12%
+108.5%
Q4 2021$347,000
-46.5%
846,850
+20.7%
0.06%
+18.0%
Q3 2021$649,000
-82.5%
701,838
-63.6%
0.05%
-73.8%
Q4 2020$3,718,000
-32.7%
1,926,594
-12.4%
0.19%
-36.1%
Q3 2020$5,522,000
+13.1%
2,200,0000.0%0.30%
+20.1%
Q2 2020$4,884,0002,200,0000.25%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders